Chris Freeman Guardant Health, Inc. (GH) insider trading activity

Chris Freeman is Chief Commercial Officer of Guardant Health, Inc.. Currently has a direct ownership of 34,669 shares of GH, which is worth approximately $1.17 Million. The most recent transaction as insider was on Jan 01, 2025, when has been sold 1,183 shares (Common Stock) at a price of $30.55 per share, resulting in proceeds of $36,140. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.7K

10.23% 3M change

137.9% 12M change

Total Value Held $1.17 Million

Chris Freeman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 01 2025	SELL Payment of exercise price or tax liability	$36,140 $30.55 p/Share	1,183 Reduced 3.3%	34,669 Common Stock
Jan 01 2025	BUY Exercise of conversion of derivative security	-	3,595 Added 9.11%	35,852 Common Stock
Dec 15 2024	SELL Payment of exercise price or tax liability	$20,751 $34.76 p/Share	597 Reduced 1.82%	32,257 Common Stock
Dec 15 2024	BUY Exercise of conversion of derivative security	-	1,402 Added 4.09%	32,854 Common Stock
Oct 01 2024	SELL Payment of exercise price or tax liability	$80,074 $22.12 p/Share	3,620 Reduced 10.32%	31,452 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	-	8,498 Added 19.5%	35,072 Common Stock
Sep 15 2024	SELL Payment of exercise price or tax liability	$15,993 $26.79 p/Share	597 Reduced 2.2%	26,574 Common Stock
Sep 15 2024	BUY Exercise of conversion of derivative security	-	1,402 Added 4.91%	27,171 Common Stock
Jul 01 2024	SELL Payment of exercise price or tax liability	$21,421 $28.26 p/Share	758 Reduced 2.86%	25,769 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	-	1,928 Added 6.78%	26,527 Common Stock
Jun 15 2024	SELL Payment of exercise price or tax liability	$86,702 $30.21 p/Share	2,870 Reduced 10.45%	24,599 Common Stock
Jun 15 2024	BUY Exercise of conversion of derivative security	-	10,402 Added 27.47%	27,469 Common Stock
Apr 01 2024	SELL Payment of exercise price or tax liability	$10,752 $20.25 p/Share	531 Reduced 3.22%	15,971 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	-	1,929 Added 10.47%	16,502 Common Stock
Jan 01 2024	SELL Payment of exercise price or tax liability	$17,149 $27.05 p/Share	634 Reduced 4.17%	14,573 Common Stock
Jan 01 2024	BUY Exercise of conversion of derivative security	-	1,928 Added 11.25%	15,207 Common Stock
Oct 01 2023	SELL Payment of exercise price or tax liability	$63,073 $29.64 p/Share	2,128 Reduced 13.81%	13,279 Common Stock
Oct 01 2023	BUY Exercise of conversion of derivative security	-	7,713 Added 33.36%	15,407 Common Stock
Jun 15 2023	SELL Payment of exercise price or tax liability	$50,959 $37.86 p/Share	1,346 Reduced 14.89%	7,694 Common Stock
Jun 15 2023	BUY Exercise of conversion of derivative security	-	4,879 Added 35.05%	9,040 Common Stock
Jun 15 2022	SELL Payment of exercise price or tax liability	$64,853 $38.42 p/Share	1,688 Reduced 34.6%	3,191 Common Stock
Jun 15 2022	BUY Exercise of conversion of derivative security	-	4,879 Added 50.0%	4,879 Common Stock

Chris Freeman

Chief Commercial Officer

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GH shares.

Notify only if

Value

Insider Trading

Get notified when an Guardant Health, Inc. insider buys or sells GH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Guardant Health, Inc.

Track Activities on GH

Account